Abstracts

Malignant tumors of the appendix: A retrospective study

Background Malignant tumors of the appendix are a rare group of tumors often found fortuitously during surgical removal of the appendix, representing approximately 2% of...

06/27/2022

Role of carcinoembryonic antigen as a prognostic marker in colorectal cancer

Background Carcinoembryonic antigen (CEA), is the most widely used tumour marker for colorectal (CRC) for decades. Because of the low diagnostic value, mostly due to the...

06/27/2022

Differences between right and left colon cancer among Albanian patients

Background Colon cancer (CC) is among the most frequently diagnosed cancers in the Western world. It is considered as a two entity cancer: right-sided colon cancer (RCC)...

06/27/2022

Epidemiological evolution of colorectal cancer over 10 years: Incidence, mortality and survival: Experience of the medical oncology department of Fez

Background Colorectal cancer is one of the most common types of cancer worldwide with an increase incidence over the years. The purpose of this study was to assess trend...

Soukaina El Anssari ;

Zineb Benbrahim ;

Youssef Elhaitmy ;

Imad Elbadisy ;

Fouad Abbass ;

Lamiae Amaadour ;

Karima Oualla ;

Samia Arifi ;

06/27/2022

Outcomes in patients with locally advanced esophageal cancer after neoadjuvant concurrent chemoradiation: A retrospective study from low- to middle-income countries

Background Esophageal cancer is a highly aggressive tumor often associated with poor prognosis. Globally the incidence and prevalence rates of esophageal cancer vary a l...

06/27/2022

Response to perioperative chemotherapy in locally advanced gastric cancer

Background Gastric cancer was the 6th most frequent tumor worldwide in 2020. The prognosis of patients with gastric and gastrooesophageal junction (GEJ) adenocarcinoma i...

06/27/2022

Real-world data: Different administration strategies of fruquintinib for metastatic colorectal cancer

Background Targeted therapy is currently the third-line standard treatment for advanced colorectal cancer. In actual clinical practice, there are many experts who choose...

06/27/2022

ON203: A new antibody targeting the oxidized form of macrophage migration inhibitory factor demonstrates antitumorigenic activity and TME modulation in patient-derived CRC tumoroids

Background The tumor microenvironment (TME) determines therapeutic response, and its modulation can help to overcome therapeutic resistance. Macrophage migration inhibit...

06/27/2022

Efficacy and safety of immune checkpoint inhibitors in older HCC patients: A real-world study

Background To explore efficacy and safety of Immune Checkpoint Inhibitors (ICIs) in patients ≥ 75 years old in a real-world situation.

06/27/2022

The molecular-metabolic interplay in metastatic gastrointestinal stromal tumors (GISTs): The predictive role of body mass index

Background KIT exon 11 Pathogenic Variants (PVs) are the most frequent mutations in Gastrointestinal Stromal Tumors (GISTs). These patients represent a heterogeneous sub...

06/27/2022